144 related articles for article (PubMed ID: 25990849)
1. Cancer immunotherapy by a recombinant phage vaccine displaying EGFR mimotope: an in vivo study.
Asadi-Ghalehni M; Ghaemmaghami M; Klimka A; Javanmardi M; Navari M; Rasaee MJ
Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):274-9. PubMed ID: 25990849
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies.
Riemer AB; Kurz H; Klinger M; Scheiner O; Zielinski CC; Jensen-Jarolim E
J Natl Cancer Inst; 2005 Nov; 97(22):1663-70. PubMed ID: 16288119
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of epidermal growth factor receptor (EGFR) monoclonal antibody and induction of growth-inhibitory polyclonal antibodies by vaccination with EGFR mimotope.
Navari M; Zare M; Javanmardi M; Asadi-Ghalehni M; Modjtahedi H; Rasaee MJ
Immunopharmacol Immunotoxicol; 2014 Oct; 36(5):309-15. PubMed ID: 25070131
[TBL] [Abstract][Full Text] [Related]
4. A novel recombinant anti-epidermal growth factor receptor peptide vaccine capable of active immunization and reduction of tumor volume in a mouse model.
Asadi-Ghalehni M; Rasaee MJ; RajabiBazl M; Khosravani M; Motaghinejad M; Javanmardi M; Khalili S; Modjtahedi H; Sadroddiny E
Microbiol Immunol; 2017 Dec; 61(12):531-538. PubMed ID: 29023946
[TBL] [Abstract][Full Text] [Related]
5. Construction of a Recombinant Phage-vaccine Capable of Reducing the Growth Rate of an Established LL2 Tumor Model.
Asadi-Ghalehni M; Rasaee MJ; Namvar Asl N; Khosravani M; Rajabibazl M; Khalili S; Modjtahedi H; Sadroddiny E
Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):240-249. PubMed ID: 29908541
[TBL] [Abstract][Full Text] [Related]
6. Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab.
Wang A; Cui M; Qu H; Di J; Wang Z; Xing J; Wu F; Wu W; Wang X; Shen L; Jiang B; Su X
Oncotarget; 2016 Nov; 7(46):75293-75306. PubMed ID: 27659529
[TBL] [Abstract][Full Text] [Related]
7. B-cell epitope peptide vaccination targeting dimer interface of epidermal growth factor receptor (EGFR).
Zhu L; Zhao L; Wu M; Chen Z; Li H
Immunol Lett; 2013 Jun; 153(1-2):33-40. PubMed ID: 23871733
[TBL] [Abstract][Full Text] [Related]
8. [Immunotherapeutic effect of recombinant EGFR phage vaccine on tumors].
Liu D; Tang L; Zhou CC; Tan LS
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):728-32. PubMed ID: 17366781
[TBL] [Abstract][Full Text] [Related]
9. Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine.
Ramírez BS; Alpízar YA; Fernández DR; Hidalgo GG; Capote AR; Rodríguez RP; Fernández LE
Vaccine; 2008 Sep; 26(38):4918-26. PubMed ID: 18672015
[TBL] [Abstract][Full Text] [Related]
10. Epitope-specific antibody response to Mel-CAM induced by mimotope immunization.
Hafner C; Wagner S; Jasinska J; Allwardt D; Scheiner O; Wolff K; Pehamberger H; Wiedermann U; Breiteneder H
J Invest Dermatol; 2005 Jan; 124(1):125-31. PubMed ID: 15654965
[TBL] [Abstract][Full Text] [Related]
11. A mimotope peptide-based anti-cancer vaccine selected by BAT monoclonal antibody.
Hardy B; Raiter A
Vaccine; 2005 Jul; 23(34):4283-91. PubMed ID: 15919139
[TBL] [Abstract][Full Text] [Related]
12. A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors.
Tobias J; Battin C; De Sousa Linhares A; Lebens M; Baier K; Ambroz K; Drinić M; Högler S; Inic-Kanada A; Garner-Spitzer E; Preusser M; Kenner L; Kundi M; Zielinski CC; Steinberger P; Wiedermann U
Front Immunol; 2020; 11():895. PubMed ID: 32528470
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice].
Li XH; Tang L; Liu D; Sun HM; Zhou CC; Tan LS; Wang LP; Zhang PD; Zhang SQ
Ai Zheng; 2006 Oct; 25(10):1221-6. PubMed ID: 17059764
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic activity in Fasciola hepatica is reduced by the administration of cathepsin L mimotopes.
Villa-Mancera A; Quiroz-Romero H; Correa D; Alonso RA
J Helminthol; 2011 Mar; 85(1):51-5. PubMed ID: 20416126
[TBL] [Abstract][Full Text] [Related]
15. CIGB-247: a VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors.
Bequet-Romero M; Morera Y; Ayala-Ávila M; Ancizar J; Soria Y; Blanco A; Suárez-Alba J; Gavilondo JV
Vaccine; 2012 Feb; 30(10):1790-9. PubMed ID: 22240345
[TBL] [Abstract][Full Text] [Related]
16. Epitope-specific antibody response to IgE by mimotope immunization.
Rudolf MP; Vogel M; Kricek F; Ruf C; Zürcher AW; Reuschel R; Auer M; Miescher S; Stadler BM
J Immunol; 1998 Apr; 160(7):3315-21. PubMed ID: 9531289
[TBL] [Abstract][Full Text] [Related]
17. A naturally occurring mutant human epidermal growth factor receptor as a target for peptide vaccine immunotherapy of tumors.
Moscatello DK; Ramirez G; Wong AJ
Cancer Res; 1997 Apr; 57(8):1419-24. PubMed ID: 9108438
[TBL] [Abstract][Full Text] [Related]
18. Oral anti-IgE immunization with epitope-displaying phage.
Zuercher AW; Miescher SM; Vogel M; Rudolf MP; Stadler MB; Stadler BM
Eur J Immunol; 2000 Jan; 30(1):128-35. PubMed ID: 10602034
[TBL] [Abstract][Full Text] [Related]
19. Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies.
Li M; Yan Z; Han W; Zhang Y
Cell Immunol; 2006 Feb; 239(2):136-43. PubMed ID: 16814270
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
